Pharmacological analysis of norepinephrine and 5-hydroxytryptamine removal from the pulmonary circulation: differentiation of uptake sites for each amine.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001667:Binding, Competitive; D003042:Cocaine / Q000494:pharmacology; D006892:Hydroxydopamines / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology; D008168:Lung / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D006892:Hydroxydopamines; D014662:Vasoconstrictor Agents; D009647:Normetanephrine; D010643:Phenoxybenzamine; D000628:Aminophylline; D012701:Serotonin; D010293:Pargyline; D011433:Propranolol; D003042:Cocaine; D007099:Imipramine; D009638:Norepinephrine; D010646:Phentolamine